InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Landry Robert E, Chief Financial Officer. Officer active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 15 reports have been recorded. Total volume traded: €373k. The latest transaction was filed on 7 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations15 total
€551,7711,500 shares@ €367.84710.0008% mcap6.5% of flow
Common Stock
SEC:0001883850-22-000040:0·
€541,4291,500 shares@ €360.95290.0007% mcap6.4% of flow
Common Stock
SEC:0001883850-22-000028:0·
€631,7971,250 shares@ €505.43740.0009% mcap7.5% of flow
Common Stock
SEC:0001883850-22-000022:0·
€188,262300 shares@ €627.53920.0003% mcap2.2% of flow
Common Stock
SEC:0001708138-22-000028:0·
€185,152300 shares@ €617.17350.0003% mcap2.2% of flow
Common Stock
SEC:0001708138-22-000022:0·
€738,0521,500 shares@ €492.03470.0010% mcap23.3% of flow
Common Stock
SEC:0001883850-21-000028·
€738,0521,500 shares@ €492.03470.0010% mcap8.7% of flow
Common Stock
SEC:0001883850-21-000028:0·
03,971 shares0
Common Stock
SEC:0001708138-21-000096·
03,971 shares0
Common Stock
SEC:0001708138-21-000096:0·
€1m3,750 shares@ €351.61290.0018% mcap41.6% of flow
Common Stock
SEC:0001708138-21-000088·
€1m3,750 shares@ €351.61290.0018% mcap15.6% of flow
Common Stock
SEC:0001708138-21-000088:0·
€470,4971,000 shares@ €470.49690.0006% mcap14.8% of flow
Common Stock
SEC:0001708138-21-000070·
€470,4971,000 shares@ €470.49690.0006% mcap5.6% of flow
Common Stock
SEC:0001708138-21-000070:0·
€645,3682,000 shares@ €322.68420.0009% mcap20.3% of flow
Common Stock
SEC:0001708138-21-000050·
€645,3682,000 shares@ €322.68420.0009% mcap7.6% of flow
Common Stock
SEC:0001708138-21-000050:0·
15 of 15 declarations
About Landry Robert E
Robert E Landry is an executive at REGENERON PHARMACEUTICALS, INC.
